CONMED CORPORATION Business Acquisition, Pro Forma Net Income (Loss)
CONMED CORPORATION (CNMD) reported Business Acquisition, Pro Forma Net Income (Loss) of $44.36 million for the 12-month period ending 2019-12-31, per its 10-K filed 2022-02-22.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2022-02-22
- CONMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2019-12-31 was $18.32M, a 54.36% increase year-over-year.
- CONMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2019-09-30 was $8.68M.
- CONMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2019-06-30 was $8.63M, a 356.35% increase year-over-year.
- CONMED CORPORATION business acquisition, pro forma net income (loss) for the quarter ending 2019-03-31 was $8.74M.
- CONMED CORPORATION business acquisition, pro forma net income (loss) for fiscal 2019 was $44.36M, a 326.26% increase from fiscal 2018.
- CONMED CORPORATION business acquisition, pro forma net income (loss) for fiscal 2018 was $10.41M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2019-12-31 | $18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $26.99M derived: sum of 2 quarters · filed 2022-02-22 | $35.62M derived: sum of 3 quarters · filed 2022-02-22 | $44.36M 10-K · filed 2022-02-22 |
| 2019-09-30 | $8.68M 10-Q · filed 2020-10-29 | $17.30M derived: sum of 2 quarters · filed 2020-10-29 | $26.05M 10-Q · filed 2020-10-29 | $37.91M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $8.63M 10-Q · filed 2020-07-30 | $17.37M 10-Q · filed 2020-07-30 | $29.24M derived: sum of 3 quarters · filed 2021-02-22 | $29.10M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $8.74M 10-Q · filed 2020-04-30 | $20.61M derived: sum of 2 quarters · filed 2021-02-22 | $20.47M derived: sum of 3 quarters · filed 2021-02-22 | $22.36M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $11.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $11.73M derived: sum of 2 quarters · filed 2021-02-22 | $13.62M derived: sum of 3 quarters · filed 2021-02-22 | $10.41M 10-K · filed 2021-02-22 |
| 2018-09-30 | -$140.00K 10-Q · filed 2019-10-31 | $1.75M derived: sum of 2 quarters · filed 2019-10-31 | -$1.46M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $1.89M 10-Q · filed 2019-08-01 | -$1.32M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | -$3.21M 10-Q · filed 2019-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |